Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that the 45th subject has been enrolled in its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in ...
Looking for something artsy to do in the Charleston area? We rounded up three community arts events taking place throughout ...
The US Department of State has just issued a worldwide security alert urging Americans abroad to exercise increased caution amid rising global tensions following US combat operations in Iran. The ...
Gary Washburn joins the program to discuss the Celtics development program, Jaylen Brown's internal growth, and what to make ...
Food delivery company DoorDash said on Monday it is launching an emergency relief program to help U.S. gig workers offset rising fuel costs. The move comes as U.S. gig workers grapple with ...
Louisville basketball has taken steps forward under Pat Kelsey, but Saturday's NCAA Tournament loss to Michigan State shows ...
Oil Price US on MSN
Trump's Iran Uranium Dilemma Raises Stakes for Oil Markets
Securing Iran's enriched uranium likely requires U.S. ground troops, risking major escalation despite airstrikes already ...
Verra Mobility (NASDAQ:VRRM) highlighted its financial profile, segment growth outlook, and capital allocation framework ...
MyChoice, a Canadian insurtech improving submission quality and underwriting confidence in the broker and carrier channels, ...
Morgan Stanley outlined four Japanese chemical stocks as its preferred picks in the sector, citing opportunities despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results